Management issues in thoracic oncology

E-poster session
Chairs: S. Lang (Jena, Germany), G. Hardavella (Athens, Greece)

Evaluating the outcomes of patients with haemoptysis referred to two rapid-access lung cancer clinics in the UK J. Noble (Bristol, United Kingdom), H. Mcdill (Bristol, United Kingdom), C. Clarke (Bristol, United Kingdom), E. Barton (Bristol, United Kingdom), M. Plummeridge (Bristol, United Kingdom), A. Bibby (Bristol, United Kingdom), A. Low (Bristol, United Kingdom)
Rationalising the lung cancer diagnostic pathway with CT triage; a single centre UK experience. E. Barton (Bristol, United Kingdom), H. Mcdill (Bristol, United Kingdom), J. Noble (Bristol, United Kingdom), M. Plummeridge (Bristol, United Kingdom), A. Bibby (Bristol, United Kingdom)
The role of a dedicated chest x-ray reporting tool in the lung cancer diagnostic pathway H. Mcdill (Bristol (Avon), United Kingdom), J. Noble (Bristol (Avon), United Kingdom), E. Barton (Bristol (Avon), United Kingdom), C. Clarke (Bristol (Avon), United Kingdom), M. Plummeridge (Bristol (Avon), United Kingdom), A. Bibby (Bristol (Avon), United Kingdom), A. Low (Bristol (Avon), United Kingdom)
The travel burden for patients diagnosed with lung cancer at a District General Hospital in South East London. P. Denniston (London, United Kingdom), R. Sayers (London, United Kingdom), E. Alveyn (London, United Kingdom), N. Shah (London, United Kingdom)
Route of referral correlates to lung cancer stage and with outcomes at a District General Hospital in South East London. P. Denniston (London, United Kingdom), R. Sayers (London, United Kingdom), E. Alveyn (London, United Kingdom), N. Shah (London, United Kingdom)
RAPID lung cancer diagnostic and care pathway from referral to treatment A. Amir (York, United Kingdom), A. Spray (York, United Kingdom), N. Haley (York, United Kingdom), K. Gracie (Hamilton, New Zealand), A. Gill (York, United Kingdom)
Transforming the Portsmouth Hospitals Lung Cancer Pathway (LCP) L. Fox (Portsmouth, United Kingdom), D. Lodge (Salisbury, United Kingdom), K. Bentley (Portsmouth, United Kingdom), L. Wiffen (Portsmouth, United Kingdom), C. Bradley (Portsmouth, United Kingdom), M. Ibrahim (Portsmouth, United Kingdom), A. Hicks (Portsmouth, United Kingdom)
Does a MultiDisciplinary Team approach affect time to treatment in NSCLC? F. Leoncini (Brescia, Italy), G. Levi (Brescia, Italy), M. Novali (Brescia, Italy), F. Quadri (Brescia, Italy), E. Martinelli (Brescia, Italy), M. Bezzi (Brescia, Italy)
Factors associated with lung cancer in patients referred to a fast-track clinic H. Mcdill (Bristol (Avon), United Kingdom), J. Noble (Bristol (Avon), United Kingdom), E. Barton (Bristol (Avon), United Kingdom), C. Clarke (Bristol (Avon), United Kingdom), M. Plummeridge (Bristol (Avon), United Kingdom), A. Low (Bristol (Avon), United Kingdom), A. Bibby (Bristol (Avon), United Kingdom)
Nutritional assessment for patients with lung cancer a. khouloud (Sfax, Tunisia), A. Hajer (Sfax, Tunisia), K. Nessrine (Sfax, Tunisia), Y. Ilhem (Sfax, Tunisia), F. Walid (Sfax, Tunisia), K. Sami (Sfax, Tunisia)
Evolution in the pathological study of lung cancer A. Martinez Mesa (Malaga, Spain), N. Reina Marfil (Malaga, Spain), E. Cabrera Cesar (Malaga, Spain), A. Aguilar Galvez (Malaga, Spain), E. Sanchez (Malaga, Spain), M. Fernandez Aguirre (Malaga, Spain)
Towards personalized treatment in non-small-cell lung carcinoma A. Martinez Mesa (Malaga, Spain), N. Reina Marfil (Malaga, Spain), E. Cabrera Cesar (Malaga, Spain), A. Aguilar Galvez (Malaga, Spain), E. Sanchez Alvarez (Malaga, Spain), M. Vera Sanchez (Malaga, Spain)
EQ-5D-3L questionnaire for quality of life assessment among lung cancer patients B. Ben Bdira (Sousse, Tunisia), I. Gargouri (Sousse, Tunisia), W. Benzarti (Sousse, Tunisia), S. Aissa (Sousse, Tunisia), A. Knaz (Sousse, Tunisia), A. Hayouni (Sousse, Tunisia), A. Abdelghani (Sousse, Tunisia), A. Garrouch (Sousse, Tunisia), M. Benzarti (Sousse, Tunisia)
Characteristics of lung cancer in our hospital in the last two years S. Jaurrieta Largo (Valladolid, Spain), R. López Castro (Valladolid, Spain), M. Belver Blanco (Valladolid, Spain), B. De Vega Sánchez (Valladolid, Spain), V. Roig Figueroa (Valladolid, Spain), C. Disdier Vicente (Valladolid, Spain)
Our experience and outcomes following indwelling pleural catheter (IPC) insertion at the University Hospital Coventry and Warwickshire (UHCW) and the effect of primary tumour site on outcomes. V. Ahluwalia (Coventry, United Kingdom), V. Nathwani (Coventry , United Kingdom), J. Glover (Coventry , United Kingdom)
Assessing the role of pleural fluid in current cancer diagnostic pathway. C. Doig (Chertsey, United Kingdom), C. Butter (Chertsey, United Kingdom), N. Hadjisavvas (Chertsey, United Kingdom), S. Saikia (Chertsey, United Kingdom), A. Fawzi (Chertsey, United Kingdom), M. Hewish (Chertsey, United Kingdom), S. Sharma (Chertsey, United Kingdom)
Quality of life and psycho-affective disorders in patients treated for lung cancer H. Snène (Tunis, Tunisia), L. Kaabi (Tunis, Tunisia), H. Blibech (Tunis, Tunisia), D. Belkhir (Tunis, Tunisia), A. Zaafouri (Tunis, Tunisia), M. Ben Rhouma (Tunis, Tunisia), N. Mehiri (Tunis, Tunisia), N. Ben Salah (Tunis, Tunisia), B. Louzir (Tunis, Tunisia)
Performance and safety of endoscopic procedures in superior vena cava syndrome C. Boily-Daoust (Québec, Canada), A. Plante (Québec, Canada), C. Adam (Québec, Canada), M. Fortin (Québec, Canada)